The carnage in the biotech space in Q4 of last year was devastating to a lot of portfolios, and many of the stocks in the space became victims of aggressive tax-loss selling before year end to add insult to injury. But, rejoice, dear investor! That just means we have some great values lying around on […]
CLVS
Sarepta Therapeutics’ Eteplirsen Study Reveals Benefits to Patients (SRPT)
Sarepta Therapeutics (NASDAQ: SRPT), an RNA-based therapeutics company that develops drugs to treat serious, life-threatening, rare and infectious diseases, announced at the Action Duchenne meeting in London that patients treated with eteplirsen continue to do well. Benefits to Patients Sarepta’s Chief Medical Officer, Dr. Ed Kaye, was speaking about the results from the phase II […]
Recent Stories
Target Corporation (NYSE:TGT) and Kroger Co (NYSE:KR) Ramp Up Fight Against COVID-19 in Stores
Amazon.com, Inc. (NASDAQ:AMZN) Closes Over 3,900 Seller Accounts In The US For Violating Fair Pricing Policies
Ford Motor Company (NYSE:F) Joins Hands With 3M Co (NYSE:MMM) And GE Healthcare To Quickly Produce Powered Air-Purifying Respirator And Ventilators
IBM (NYSE:IBM) Leads The Consortium To Provide Access To High-Performance Computing Systems To Help Researchers Find A Vaccine For COVID-19
American Airlines Group (NASDAQ:AAL) To Use Its Boeing 777-300 Passenger Planes To Fly Cargo To Europe